Monte Rosa Therapeutics shares owned by MetLife Investment Advisors
Quarter-by-quarter ownership of Monte Rosa Therapeutics (GLUE) shares owned by MetLife Investment Advisors
from 13F filings
Historical chart of MetLife Investment Advisors investment in Monte Rosa Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Monte Rosa Therapeutics held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Monte Rosa Therapeutics by MetLife Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $181k | 24k | 7.41 |
| 2025-06-30 | $110k | 24k | 4.51 |
| 2025-03-31 | $113k | 24k | 4.64 |
| 2024-12-31 | $173k | 25k | 6.94 |
| 2024-09-30 | $132k | 25k | 5.30 |
| 2023-12-31 | $103k | 18k | 5.65 |
| 2023-09-30 | $87k | 18k | 4.79 |
| 2023-06-30 | $124k | 18k | 6.85 |
| 2023-03-31 | $141k | 18k | 7.79 |
| 2022-12-31 | $138k | 18k | 7.61 |
| 2022-09-30 | $148k | 18k | 8.17 |
| 2022-06-30 | $176k | 18k | 9.69 |
| 2022-03-31 | $255k | 18k | 14.04 |
| 2021-09-30 | $106k | 4.8k | 22.28 |
More positions owned by MetLife Investment Advisors
View all positions for MetLife Investment Advisors